316 related articles for article (PubMed ID: 24265711)
21. Lymphovascular invasion: a comprehensive appraisal in colon and rectal adenocarcinoma.
Hogan J; Chang KH; Duff G; Samaha G; Kelly N; Burton M; Burton E; Coffey JC
Dis Colon Rectum; 2015 Jun; 58(6):547-55. PubMed ID: 25944426
[TBL] [Abstract][Full Text] [Related]
22. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
Shafqat H; Ali S; Salhab M; Olszewski AJ
Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
[TBL] [Abstract][Full Text] [Related]
23. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.
Kang H; O'Connell JB; Maggard MA; Sack J; Ko CY
Dis Colon Rectum; 2005 Jun; 48(6):1161-8. PubMed ID: 15868237
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic analysis of colon and rectal neuroendocrine neoplasm in different stages].
Huang YT; Jia R; Xu Q; Ji SJ; Cui HT; Xu JM
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):146-151. PubMed ID: 30862146
[No Abstract] [Full Text] [Related]
25. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database.
Huang B; Chen C; Ni M; Mo S; Cai G; Cai S
Int J Surg; 2016 Aug; 32():24-30. PubMed ID: 27321382
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors of overall survival and cancer-specific survival in patients with resected early-stage rectal adenocarcinoma: a SEER-based study.
Lee KC; Chung KC; Chen HH; Liu CC; Lu CC
J Investig Med; 2017 Dec; 65(8):1148-1154. PubMed ID: 28735257
[TBL] [Abstract][Full Text] [Related]
27. Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer.
Chang LC; Shun CT; Lin BR; Sanduleanu S; Hsu WF; Wu MS; Chiu HM
Oncologist; 2021 Sep; 26(9):e1548-e1554. PubMed ID: 33955121
[TBL] [Abstract][Full Text] [Related]
28. The effect of marital and insurance status on the survival of elderly patients with stage M1b colon cancer: a SEER-based study.
Zhou C; Zhang Y; Hu X; Fang M; Xiao S
BMC Cancer; 2021 Aug; 21(1):891. PubMed ID: 34353300
[TBL] [Abstract][Full Text] [Related]
29. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites.
Feng Z; Shi X; Zhang Q; Zhang X; Li X; Chen Z; Liu D; Sun B; Zuo Y; Ren S
Pathol Res Pract; 2019 Oct; 215(10):152560. PubMed ID: 31375274
[TBL] [Abstract][Full Text] [Related]
30. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.
Lemmens V; van Steenbergen L; Janssen-Heijnen M; Martijn H; Rutten H; Coebergh JW
Acta Oncol; 2010 Aug; 49(6):784-96. PubMed ID: 20429731
[TBL] [Abstract][Full Text] [Related]
31. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer.
Johnson PM; Porter GA; Ricciardi R; Baxter NN
J Clin Oncol; 2006 Aug; 24(22):3570-5. PubMed ID: 16877723
[TBL] [Abstract][Full Text] [Related]
32. Establishing the optimum lymph node yield for diagnosis of stage III rectal cancer.
Bhangu A; Kiran RP; Brown G; Goldin R; Tekkis P
Tech Coloproctol; 2014 Aug; 18(8):709-17. PubMed ID: 24515286
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients.
Yang J; Du XL; Li ST; Wang BY; Wu YY; Chen ZL; Lv M; Shen YW; Wang X; Dong DF; Li D; Wang F; Li EX; Yi M; Yang J
PLoS One; 2016; 11(12):e0167540. PubMed ID: 27936129
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant radiation therapy for T4 non-rectal colon adenocarcinoma provides a cause-specific survival advantage: A SEER database analysis.
McLaughlin C; Kim NK; Bandyopadhyay D; Deng X; Kaplan B; Matin K; Fields EC
Radiother Oncol; 2019 Apr; 133():50-53. PubMed ID: 30935581
[TBL] [Abstract][Full Text] [Related]
35. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis.
Greene FL; Stewart AK; Norton HJ
J Clin Oncol; 2004 May; 22(10):1778-84. PubMed ID: 14769855
[TBL] [Abstract][Full Text] [Related]
36. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes.
Gunderson LL; Jessup JM; Sargent DJ; Greene FL; Stewart A
J Clin Oncol; 2010 Jan; 28(2):256-63. PubMed ID: 19949015
[TBL] [Abstract][Full Text] [Related]
37. Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients.
Landry CS; Brock G; Scoggins CR; McMasters KM; Martin RC
J Am Coll Surg; 2008 Dec; 207(6):874-81. PubMed ID: 19183534
[TBL] [Abstract][Full Text] [Related]
38. Rates of colon and rectal cancers are increasing in young adults.
O'Connell JB; Maggard MA; Liu JH; Etzioni DA; Livingston EH; Ko CY
Am Surg; 2003 Oct; 69(10):866-72. PubMed ID: 14570365
[TBL] [Abstract][Full Text] [Related]
39. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
[TBL] [Abstract][Full Text] [Related]
40. Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database.
Huang B; Feng Y; Zhu L; Xu T; Huang L; Cai G
Int J Surg; 2016 Sep; 33 Pt A():157-63. PubMed ID: 27491969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
